Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | CDK4 | P11802 | 1/20 | 0.47 |
| ▸ | CCND1 | P24385 | 1/20 | 0.47 |
| ▸ | JUN | P05412 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | BCR | P11274 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3415700 | 1.00 | CA2 (0.50) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL30337793 | 1.00 | CA2 (0.50) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL3417189 | 0.89 | MAPT (0.46) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL3417191 | 0.89 | MAPT (0.46) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL7923703 | 0.87 | CYSLTR2 (0.48) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL17666840 | 0.87 | CYSLTR2 (0.48) | CA2NFKB1CA1CA4MAPT | |
| SCHEMBL10750148 | 0.85 | CYSLTR2 (0.50) | MAPTLMNATRPA1KDM4E | |
| SCHEMBL1001649 | 0.85 | CYSLTR2 (0.50) | MAPTLMNATRPA1KDM4E | |
| SCHEMBL1072895 | 0.85 | CYSLTR2 (0.50) | MAPTLMNATRPA1KDM4E | |
| SCHEMBL1001648 | 0.85 | CYSLTR2 (0.50) | MAPTLMNATRPA1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3092046-B1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2018-04-18 | — | — | EP | claimed |
| EP-3092046-A1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2016-11-16 | — | — | EP | claimed |
| WO-2015104048-A1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2015-07-16 | — | — | WO | claimed |
| CN-117043135-A | Diester compound | 味之素株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022202703-A1 | DIESTER COMPOUND | 味の素株式会社 | 2022-09-29 | — | — | WO | disclosed |
| EP-3006543-B1 | POLYFUNCTIONAL LUBRICANT COMPOSITION | ADEKA CORP (JP) | 2021-05-26 | — | — | EP | disclosed |
| EP-3092046-B1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2018-04-18 | — | — | EP | disclosed |
| US-9738848-B2 | Polyfunctional lubricant composition | ADEKA CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| EP-3092046-A1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2016-11-16 | — | — | EP | disclosed |
| US-20160122679-A1 | POLYFUNCTIONAL LUBRICANT COMPOSITION | ADEKA CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-3006543-A1 | POLYFUNCTIONAL LUBRICANT COMPOSITION | Adeka Corporation (JP) | 2016-04-13 | — | — | EP | disclosed |
| WO-2015104048-A1 | ALKOXYLATED PRODUCT AND USE THEREOF | Hexion GmbH (DE) | 2015-07-16 | — | — | WO | disclosed |
| US-7767739-B2 | Cyanato group-containing cyclic phosphazene compound and method for producing the same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-4157324-A | High ortho etherified resole resins admixed with coreactive resins | MONSANTO COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4122054-A | High ortho etherified resole resins | MONSANTO COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4120847-A | High ortho etherified resole resins | MONSANTO COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | CENPE, CPNE4, MCM3 | CA2 261/4885NFKB1 4874/4885CA1 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.